03 Profile
Hansard to 11 November 2026 · 31,429 contributions indexed · 1,439 MPs & peers
All voices01 Voice · Academic · Long Covid
Esther Melamed
Neuroimmunologist at the University of Texas; co-author of the study
press citation on 1 topic since 26 Aug 2026 · last quoted 26 Aug 2026
02 Quoted on · 1 of 29 topics
Esther Melamed: key facts
- Kind of voice
- Academic
- Role
- Neuroimmunologist at the University of Texas; co-author of the study
- Quoted on
- Long Covid
- Tracked press citations
- 1
- Most recently quoted
- 26 Aug 2026
04 The signal · where Esther Melamed sits on long covid
Ranked 43= of 100 voices quoted in the press on long covid, level with 57 others on 1 citation.
Ranked on press citations on this topic only, not across all topics. Joint positions share a rank.
- 1=
Dr Charles ShepherdClinicianTrustee and Honorary Medical Adviser, The ME Association9 - 1=Professor Dmitry PshezhetskiyAcademicProfessorial Research Fellow, Norwich Medical School, University of East Anglia9
- 3
Dr. Ewan HunterBusiness leaderChief Data Officer, Oxford BioDynamics Plc6 - 43=Professor Dmitri PshezhetskiAcademicProfessor at Norwich Medical School, University of East Anglia1
- 43=Sophie KatzAcademicMD, MPH, Vanderbilt University Medical Center1
- 43=Esther MelamedAcademicNeuroimmunologist at the University of Texas; co-author of the study1
- 43=Angélica GuevaraAcademiclaw professor at Indiana University1
- 43=Doron DorfmanAcademiclaw professor at Seton Hall University1
Showing the leaders and the ranks around 43=, of 100 voices · See every voice on the topic →
05 On the record · press
What Esther Melamed has said
- dailystar.co.uk1
Where Esther Melamed has been quoted
- 01Severe Covid-19 'could reawaken dormant viruses' and make symptoms even worsedailystar.co.uk · 26 Aug 2026
Verbatim
“The next step is determining whether identifying and treating reactivated viruses can improve outcomes for patients with acute Covid-19 and long Covid. If our findings are validated, then it would really create a lot of urgency around developing antivirals to treat them.”
Related media coverage
Recent UK press coverage of their topics, not necessarily citing them directly.
Professors, researchers and think-tank analysts quoted on the strength of their research rather than a clinical role. Citations are counted by an automated scan of UK press coverage and may be incomplete. Roles, biographies and contact details are researched and human-reviewed before they appear here; anything not yet reviewed is simply absent rather than shown unverified. This profile was last updated on 12 Nov 2026. See the methodology for how this page is built, or email contact@bridgeheadcommunications.com to correct anything on it.